David Lawrence, Chief, Business Operations & PAO at ACORDA THERAPEUTICS INC (ACOR), sold 44,880 shares at $28.41 ($1.3M) on 2018-06-08, disclosed to the SEC on 2018-06-11.
Open-market sale of $1.3M ACOR by Chief, Business Operations & PAO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.02 | 19,880 | $557K | 44.1% |
| 2 | $28.02 | 19,880 | $557K | 44.1% |
| 3 | $28.41 | 4,000 | $114K | 9.0% |
| 4 | $29.61 | 400 | $12K | 0.9% |
| 5 | $30.58 | 500 | $15K | 1.2% |
| 6 | $31.90 | 200 |
| $6K |
| 0.5% |
| 7 | $33.10 | 20 | $662 | 0.1% |
| Total | $28.12 avg | 44,880 | $1.3M | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-01-22 | $1.7M | — | Filing → |